The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer. Hagens MJ, Luining WI, Jager A, Donswijk ML, et al. J Nucl Med 2023 Jun 29:jnumed.122.265205. doi: 10.2967/jnumed.122.265205.

Read + Share

Amedeo Smart

Independent Medical Education

Hagens MJ, Luining WI, Jager A, Donswijk ML, et al. The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer. J Nucl Med 2023 Jun 29:jnumed.122.265205. doi: 10.2967/jnumed.122.265205.
PMID: 37385673